# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ulysses S. Grant (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI002-SYN-TD
- Date: 1884-08-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Corinne Batiste, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Pre-treatment primary care review after staging. **S**

## History of present illness

Mr. Grant returns after staging. The final pathology confirmed p16-negative squamous cell carcinoma of the right tonsillar pillar, and last week's PET/CT showed no distant spread. The head and neck oncology team has recommended chemoradiation, to start in about ten days. The cold he had last week has cleared, apart from a light cough in the mornings. His throat pain is 4 of 10, down from 6 while he was coughing. He weighs 75.5 kg, 2.5 kg below his weight at intake. He saw the dietitian last week and takes soft, calorie-dense foods with two supplement drinks a day. He has smoked no cigars for three weeks and takes varenicline 1 mg twice daily after meals without nausea or changes in mood or sleep. He worries about money and about finishing his memoir during treatment, but still enjoys his writing and his visitors. He has not yet seen a dentist. **S**

| Element | Detail |
|---|---|
| Staging | p16-negative squamous cell carcinoma; PET/CT shows no distant spread |
| Treatment plan | Chemoradiation by the head and neck oncology team, starting in about ten days |
| Pain | 4 of 10, down from 6 during last week's cold |
| Weight and nutrition | 75.5 kg, down 2.5 kg from intake; dietitian seen; two supplement drinks a day |
| Tobacco | No cigars for three weeks; varenicline 1 mg twice daily tolerated |
| Mood | Worried about money and his memoir; still enjoys his writing |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Weight down 2.5 kg since intake; no fever |
| Ears, nose, mouth, and throat | Positive | Right-sided throat pain, 4 of 10, worse with swallowing; nasal congestion resolved |
| Respiratory | Positive | Light morning cough after last week's cold; no sputum, hemoptysis, or breathlessness |
| Gastrointestinal | Negative | No nausea or vomiting |
| Psychiatric | Positive | Worry about finances and his writing; interest and enjoyment preserved; PHQ-2 score 2 |

5 systems reviewed. **S**

## Current medications

- Varenicline 1 mg oral tablet, one tablet twice daily **S**
- Acetaminophen 160 mg/5 mL oral solution, 20 mL (640 mg) every 6 hours as needed for throat pain **S**
- Lidocaine viscous 2% solution, 15 mL swish and spit up to every 3 hours as needed for throat pain **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/78 mmHg; pulse 74 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 98% on room air; weight 75.5 kg; BMI 25.2 kg/m². All vital signs are synthetic.

Hemoglobin: 13.8 g/dL; White blood cell count: 7.9 10*3/uL; Platelet count: 255 10*3/uL; Sodium: 138 mmol/L; Potassium: 4.4 mmol/L; Creatinine: 0.95 mg/dL; eGFR: 90 mL/min/1.73 m²; Glucose: 90 mg/dL; Albumin: 3.6 g/dL; Throat pain (0-10): 4; PHQ-2: 2. All results are synthetic.

## Change since baseline

- Hemoglobin: 14.1 g/dL at baseline, 13.8 g/dL at this visit **S**
- White blood cell count: 8.4 10*3/uL at baseline, 7.9 10*3/uL at this visit **S**
- Platelet count: 262 10*3/uL at baseline, 255 10*3/uL at this visit **S**
- Sodium: 139 mmol/L at baseline, 138 mmol/L at this visit **S**
- Potassium: 4.3 mmol/L at baseline, 4.4 mmol/L at this visit **S**
- Creatinine: 0.98 mg/dL at baseline, 0.95 mg/dL at this visit **S**
- eGFR: 87 mL/min/1.73 m² at baseline, 90 mL/min/1.73 m² at this visit **S**
- Glucose: 92 mg/dL at baseline, 90 mg/dL at this visit **S**
- Albumin: 3.9 g/dL at baseline, 3.6 g/dL at this visit **S**
- Throat pain (0-10): 5 at baseline, 4 at this visit **S**
- PHQ-2: 1 at baseline, 2 at this visit **S**

## Immunizations given today

- Pneumococcal conjugate vaccine PCV20 **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert; lost some weight but well-appearing |
| Oropharynx | Ulcerated lesion of the right tonsillar pillar; biopsy site healed |
| Teeth and gums | Several restored teeth and gum recession; no obvious abscess |
| Neck | Firm right level II node, unchanged; no new nodes |
| Lungs | Clear |

All examination findings are synthetic. **S**

## Assessment and plan

1. **p16-negative squamous cell carcinoma of the right tonsillar pillar, staged, before chemoradiation** (C09.1). Right tonsillar primary with one involved right level II node and no distant spread on PET/CT. Chemoradiation is planned by the head and neck oncology team. Pre-treatment blood counts, electrolytes, and kidney function are normal (hemoglobin 13.8, creatinine 0.95, eGFR 90); albumin is 3.6 g/dL, down from 3.9. **S**
   - Dental evaluation this week, before radiation planning, for any needed extractions and fluoride trays.
   - Speech-language pathology swallowing baseline and preventive swallowing exercises before treatment.
   - Pneumococcal conjugate vaccine (PCV20) given today, before treatment.
   - Avoid alcohol during treatment.
2. **Nicotine dependence, cigars, three weeks abstinent** (F17.290). Abstinent for three weeks, meeting the goal of stopping before treatment begins. **S**
   - Continue varenicline 1 mg twice daily after meals.
   - Counseling today: plan for cravings during treatment, when stress and fatigue are relapse triggers.
3. **Unintended weight loss** (R63.4). Weight 75.5 kg, 3.2 percent below the 78 kg baseline; pain 4 of 10. **S**
   - Continue the dietitian's plan and the supplement drinks.
   - Weight weekly during treatment with the oncology team, which decides on a feeding tube if loss nears 10 percent.
4. **Distress about finances and his writing**. PHQ-2 score 2; worry is understandable, and interest and enjoyment are preserved. **S**
   - Offered the cancer center's social worker for financial counseling.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | CBC, basic metabolic panel, and albumin | Before and after treatment | Completed today | Hemoglobin 13.8, white count 7.9, platelets 255, sodium 138, potassium 4.4, creatinine 0.95, eGFR 90, glucose 90, all normal; albumin 3.6, down from 3.9 |
| Laboratory | Final pathology with p16 | At diagnosis | Up to date | Squamous cell carcinoma, p16-negative |
| Imaging | PET/CT for staging | Once carcinoma is confirmed | Up to date | Done last week: no distant spread |
| Laboratory | TSH | Baseline before neck radiation, then every 6 to 12 months after it | Up to date | Baseline 1.8 mIU/L at intake |
| Referral | Multidisciplinary head and neck oncology team | After tissue diagnosis | Up to date | Seen; chemoradiation recommended, starting in about ten days |
| Referral | Dental evaluation before radiation | Before radiation to the neck | Referred | Booked for this week, before radiation planning |
| Referral | Speech-language pathology swallowing baseline | Before treatment | Referred | Referred today for a baseline assessment and preventive swallowing exercises |
| Referral | Dietitian assessment | Before treatment | Up to date | Seen last week; soft, calorie-dense diet with two supplement drinks a day |
| Examination | Weight | Every visit | Completed today | 75.5 kg, 3.2 percent below baseline |
| Survey | Throat pain score (0-10) | Every visit | Completed today | 4 of 10 |
| Survey | Depression screen (PHQ-2) | Every primary care visit after the diagnosis | Completed today | Score 2 |
| Self-management | Tobacco use status and cessation counseling | Every visit | Completed today | No cigars for three weeks; relapse-prevention counseling given |
| Medication safety | Varenicline tolerance: nausea, sleep, mood, and behavior | Each visit during treatment | Completed today | No nausea, mood, sleep, or behavior change on 1 mg twice daily |
| Medication safety | Pneumococcal vaccination before cancer treatment | Once | Completed today | PCV20 given today |

## Goal progress

- Tissue diagnosis within two weeks of the first visit. Outcome by 1884-07-21: Biopsy at the otolaryngology visit two weeks after presentation. **S**
- Stop all tobacco use before treatment begins. Outcome by 1884-08-04: No cigars since mid-July 1884; varenicline continued. **S**
- Limit weight loss to less than 10% of baseline weight through treatment. In progress; target 1884-10-22. **S**
- Keep throat pain at 4 or below on the 0-10 scale most days. In progress; target 1884-10-22. **S**

## Guideline basis

- NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2025 (2025), National Comprehensive Cancer Network
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, depression and hypothyroidism monographs (2026), Aether Forge

## Follow-up

- Chemoradiation with the head and neck oncology team, starting in about ten days; that team follows his weight, pain, and blood counts weekly during treatment. Primary care visit about three weeks after treatment ends. **S**
- Next scheduled visit 1884-10-22: primary care visit three weeks after completing chemoradiation directed by the head and neck oncology team. **S**
